Navigation Links
Algeta Receives IND Approval for Alpharadin(TM) to Commence Clinical Development in the USA
Date:2/21/2008

OSLO, February 21 /PRNewswire-FirstCall/ -- Algeta ASA (OSE: ALGETA), the cancer therapeutics company, today announced that it will shortly commence clinical development of Alpharadin(TM) in HRPC patients in the USA. Algeta filed its Investigational New Drug (IND) application for its lead product Alpharadin(TM) with the United States Food and Drug Administration (FDA) in December 2007. The statutory 30 day consultation period was extended by the FDA for a further 30 days by agreement with the company and the IND has now been cleared by the FDA without any objections being made to the application. Alpharadin(TM) has already been studied in phase II clinical trials in Europe and has demonstrated a potential for a significant survival benefit in hormone-refractory prostate cancer (HRPC) patients with skeletal metastases.

An initial Phase I pharmacokinetics, biodistribution and dosimetry study (BC1-08) with Alpharadin in HRPC patients with skeletal metastases will be conducted at the Memorial Sloan-Kettering Cancer Center in New York, one of the world's leading oncology centers. This US trial will further expand the information obtained in a similar phase I study (BC1-05) conducted at the Royal Marsden Hospital in London, for which patient enrolment has recently been completed.

Following the start up of the BC1-08 trial, Algeta will continue discussions with the FDA to agree on the design of the further clinical development program for Alpharadin(TM)

"We are delighted to have been given the clearance by FDA to advance Alpharadin into clinical development in the United States, and to be working with one of the world's leading cancer centers on our clinical program," said Dr. Thomas Ramdahl, President and CEO of Algeta. "There is a great unmet medical need among men suffering from HRPC with skeletal metastases and the opening of this US clinical trial will be an important step in our overall clinical development of Alpharadin. As earlier announ
'/>"/>

SOURCE Algeta
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
Cats To Aid in Prevention of Bird Flu
...sands of patients hope came true, YES! A new treat...and //. A drug named Tarceva, was the new one whi...ancer patients. When taken as a pill, the drug ap...cines Consortium (one per day), reduces the pressu...
...Chief Minister of Assam Tarun Gogoi had today unde...cal Sciences (AIIMS) for dehydration //. Sources ...d to India yesterday, after a 12-day tour of Europ...AIIMS as he had complained of uneasiness. Doctors...
...AGO - A relaxation technique known as transcendent...ce insulin resistance among patients with coronary...ne 12 issue of Archives of Internal Medicine, one ...cendental meditation, derived from the ancient Ved...
Other Medicine News:Health News:Meditation may Improve Cardiac Risk Factors in Patients with Coronary Heart Disease 2
(Date:8/26/2008).../ -- The Oregon Tourism Commission,launched its ne...ng Program,(Q Care) this week on http://www.Orego... created to support the tourism and,hospitality in...hasizing,the importance of quality customer servic...d resources to better serve Oregon,s visitors., "...
(Date:8/26/2008)...wswire/ -- Healthpoint today announced,that it has...iveness of a,widely prescribed enzymatic debriding...cars. The pilot study was prompted, in part, by cl...ophic scars and beneficial healing,properties asso... "Given the findings from the peer-reviewed litera...
(Date:8/25/2008)... Menstrual Blood May Offer Long-Lasting ...LDSMAR, Fla., Aug. 25 /- Time. It is ...hat there never seems to be enough,of it. And the ...hing just,for herself usually pales in comparison ...s led many women in need of quality time to seek o...
(Date:8/25/2008)...tment and Japanese Development Studies ... August 25 /- Genmab has,an...in chronic lymphocytic,leukemia and non-Hodgkin,s ...plans to begin four studies of,ofatumumab in chron...odgkin,s lymphoma (NHL) this year., "Genmab and G...
Breaking Medicine Technology:Oregon Tourism Commission Unveils New Online Customer Service Training Program 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3Going Beyond 'Spa Day': Giving Women the Opportunity to Do Something Proactive Which May Lead to Long Term Health Benefits 2Genmab Announces Upcoming Ofatumumab Studies 2Genmab Announces Upcoming Ofatumumab Studies 3Genmab Announces Upcoming Ofatumumab Studies 4Justice Department Reaches Settlement to Improve Conditions at a Nebraska Developmental Center 22972 1Justice Department Reaches Settlement to Improve Conditions at a Nebraska Developmental Center 22972 2Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 1Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise 6313 2Patient Receives vProtect 28TM 29 Luminal Shield in First Ever Vulnerable Plaque Clinical Trial 2557 1Patient Receives vProtect 28TM 29 Luminal Shield in First Ever Vulnerable Plaque Clinical Trial 2557 2Patient Receives vProtect 28TM 29 Luminal Shield in First Ever Vulnerable Plaque Clinical Trial 2557 3Research Links Low HDL Levels With Memory Loss 22970 1Research Links Low HDL Levels With Memory Loss 22970 2
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus
Rapid Immunoassay for the detection of Respiratory Syncytial Virus.
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients.
...en EZ RSV Test utilizes a new, improved format tha...id RSV detection. The testing device employs innov...ied reagents have already been applied to the test...ss, with clear-cut results shown by the appearance...
Medicine Products: